BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28906578)

  • 1. Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.
    Roquer J; Vivanco-Hidalgo RM; Capellades J; Ois A; Cuadrado-Godia E; Giralt-Steinhauer E; Soriano-Tárraga C; Mola-Caminal M; Serra-Martínez M; Avellaneda-Gómez C; Jiménez-Conde J; Rodríguez-Campello A
    Eur J Neurol; 2018 Jan; 25(1):83-89. PubMed ID: 28906578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage.
    Roquer J; Vivanco Hidalgo RM; Ois A; Rodríguez Campello A; Cuadrado Godia E; Giralt Steinhauer E; Gómez González A; Soriano-Tarraga C; Jiménez Conde J
    Neurology; 2017 Feb; 88(9):885-891. PubMed ID: 28148636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultraearly hematoma growth in active intracerebral hemorrhage.
    Rodriguez-Luna D; Coscojuela P; Rubiera M; Hill MD; Dowlatshahi D; Aviv RI; Silva Y; Dzialowski I; Lum C; Czlonkowska A; Boulanger JM; Kase CS; Gubitz G; Bhatia R; Padma V; Roy J; Tomasello A; Demchuk AM; Molina CA;
    Neurology; 2016 Jul; 87(4):357-64. PubMed ID: 27343067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage.
    Rodriguez-Luna D; Rubiera M; Ribo M; Coscojuela P; Piñeiro S; Pagola J; Hernandez-Guillamon M; Ibarra B; Romero F; Alvarez-Sabin J; Montaner J; Molina CA
    Neurology; 2011 Oct; 77(17):1599-604. PubMed ID: 21998314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Age on Characteristics and Mortality of Intracerebral Hemorrhage in the Oldest-Old.
    Forti P; Maioli F; Domenico Spampinato M; Barbara C; Nativio V; Coveri M; Zoli M; Simonetti L; Di Pasquale G; Procaccianti G
    Cerebrovasc Dis; 2016; 42(5-6):485-492. PubMed ID: 27595266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of atrial fibrillation and antithrombotics on outcome in intracerebral hemorrhage.
    Roquer J; Vivanco-Hidalgo RM; Prats-Sánchez LL; Martínez-Domeño A; Guisado-Alonso D; Cuadrado-Godia E; Giralt Steinhauer E; Jiménez-Conde J; Rodríguez-Campello A; Martí-Fàbregas J; Ois A
    Neurology; 2019 Nov; 93(19):e1820-e1829. PubMed ID: 31597709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
    Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
    J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Ultraearly Hematoma Growth and Hypodensities for Outcome Prediction after Intracerebral Hemorrhage.
    Lei K; Wei S; Liu X; Yuan X; Pei L; Xu Y; Song B; Sun S
    World Neurosurg; 2020 Mar; 135():e610-e615. PubMed ID: 31870816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Ability of Ultraearly Hematoma Growth and Spot Sign for Redefined Hematoma Expansion in Patients with Spontaneous Intracerebral Hemorrhage.
    Li J; Liao X; Yu Z; Li H; Zheng J
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105950. PubMed ID: 34214962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hematoma density heterogeneity and ultraearly hematoma growth in predicting hematoma expansion in patients with spontaneous intracerebral hemorrhage.
    Yu Z; Ma L; Zheng J; Guo R; Li M; Wang X; Lin S; Li H; You C
    J Neurol Sci; 2017 Aug; 379():44-48. PubMed ID: 28716277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ultra-early hematoma growth and blend sign for predicting hematoma expansion and functional outcome.
    Yuan L; Shen YQ; Xie XF; Yang WS; Li R; Deng L; Li Q; Xie P
    Clin Neurol Neurosurg; 2020 Feb; 189():105625. PubMed ID: 31835077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage.
    Yildiz OK; Arsava EM; Akpinar E; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):760-6. PubMed ID: 21683617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
    JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Ultra-Early Hematoma Growth and Common Noncontrast Computed Tomography Features in Predicting Hematoma Enlargement in Patients with Spontaneous Intracerebral Hemorrhage.
    Xiang Y; Zhang T; Li Y; Liu J; Xu H; He W; Chen Q; Yang Y
    World Neurosurg; 2020 Feb; 134():e75-e81. PubMed ID: 31648055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Ultraearly Hematoma Growth in Spontaneous Intracerebral Hemorrhage Patients Receiving Hematoma Evacuation.
    Yu Z; Zheng J; Guo R; Ma L; Li M; Wang X; Lin S; You C; Li H
    World Neurosurg; 2018 Jan; 109():e651-e654. PubMed ID: 29054774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.
    Moussouttas M; Malhotra R; Fernandez L; Maltenfort M; Holowecki M; Delgado J; Lawson N; Badjatia N
    Neurocrit Care; 2010 Feb; 12(1):24-9. PubMed ID: 19844810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
    Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
    Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.
    Camps-Renom P; Alejaldre-Monforte A; Delgado-Mederos R; Martínez-Domeño A; Prats-Sánchez L; Pascual-Goñi E; Martí-Fàbregas J
    Eur J Neurol; 2017 Feb; 24(2):302-308. PubMed ID: 27801531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.